Invention Grant
- Patent Title: Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof
-
Application No.: US17386504Application Date: 2021-07-27
-
Publication No.: US11685779B2Publication Date: 2023-06-27
- Inventor: David Scott Johnson , Sheila Keating , Adam Shultz Adler , Michael Asensio , Kacy Stadtmiller , Emily Benzie , Ariel Niedecken , Angelica V. Medina-Cucurella , Rena Aviva Mizrahi , Yoong Wearn Lim
- Applicant: GigaGen, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: GigaGen, Inc.
- Current Assignee: GigaGen, Inc.
- Current Assignee Address: US CA San Carlos
- Agency: Fenwick & West LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P31/14 ; C40B40/10 ; A61K39/00
Abstract:
Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the RPPs.
Information query
